125 related articles for article (PubMed ID: 29732979)
1. Cold Physical Plasma-Treated Buffered Saline Solution as Effective Agent Against Pancreatic Cancer Cells.
Bekeschus S; Käding A; Schröder T; Wende K; Hackbarth C; Liedtke KR; van der Linde J; von Woedtke T; Heidecke CD; Partecke LI
Anticancer Agents Med Chem; 2018; 18(6):824-831. PubMed ID: 29732979
[TBL] [Abstract][Full Text] [Related]
2. Cold Physical Plasma Selectively Elicits Apoptosis in Murine Pancreatic Cancer Cells
Liedtke KR; Diedrich S; Pati O; Freund E; Flieger R; Heidecke CD; Partecke LI; Bekeschus S
Anticancer Res; 2018 Oct; 38(10):5655-5663. PubMed ID: 30275184
[TBL] [Abstract][Full Text] [Related]
3. Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivo.
Freund E; Liedtke KR; van der Linde J; Metelmann HR; Heidecke CD; Partecke LI; Bekeschus S
Sci Rep; 2019 Jan; 9(1):634. PubMed ID: 30679720
[TBL] [Abstract][Full Text] [Related]
4. Non-thermal plasma-treated solution demonstrates antitumor activity against pancreatic cancer cells in vitro and in vivo.
Liedtke KR; Bekeschus S; Kaeding A; Hackbarth C; Kuehn JP; Heidecke CD; von Bernstorff W; von Woedtke T; Partecke LI
Sci Rep; 2017 Aug; 7(1):8319. PubMed ID: 28814809
[TBL] [Abstract][Full Text] [Related]
5. Pulsed Electric Field Treatment Enhances the Cytotoxicity of Plasma-Activated Liquids in a Three-Dimensional Human Colorectal Cancer Cell Model.
Griseti E; Kolosnjaj-Tabi J; Gibot L; Fourquaux I; Rols MP; Yousfi M; Merbahi N; Golzio M
Sci Rep; 2019 May; 9(1):7583. PubMed ID: 31110227
[TBL] [Abstract][Full Text] [Related]
6. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
[TBL] [Abstract][Full Text] [Related]
7. Effect of Plasma-Activated Lactated Ringer's Solution on Pancreatic Cancer Cells In Vitro and In Vivo.
Sato Y; Yamada S; Takeda S; Hattori N; Nakamura K; Tanaka H; Mizuno M; Hori M; Kodera Y
Ann Surg Oncol; 2018 Jan; 25(1):299-307. PubMed ID: 29139022
[TBL] [Abstract][Full Text] [Related]
8. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
[TBL] [Abstract][Full Text] [Related]
9. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
10. Selective Apoptotic Effect of Plasma Activated Liquids on Human Cancer Cell Lines.
Sersenová D; Machala Z; Repiská V; Gbelcová H
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299530
[TBL] [Abstract][Full Text] [Related]
11. The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer.
Murata Y; Kokuryo T; Yokoyama Y; Yamaguchi J; Miwa T; Shibuya M; Yamamoto Y; Nagino M
Anticancer Res; 2017 Feb; 37(2):589-598. PubMed ID: 28179305
[TBL] [Abstract][Full Text] [Related]
12. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
[TBL] [Abstract][Full Text] [Related]
13. Tissue tolerable plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivo.
Partecke LI; Evert K; Haugk J; Doering F; Normann L; Diedrich S; Weiss FU; Evert M; Huebner NO; Guenther C; Heidecke CD; Kramer A; Bussiahn R; Weltmann KD; Pati O; Bender C; von Bernstorff W
BMC Cancer; 2012 Oct; 12():473. PubMed ID: 23066891
[TBL] [Abstract][Full Text] [Related]
14. Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines.
Harvey KA; Xu Z; Saaddatzadeh MR; Wang H; Pollok K; Cohen-Gadol AA; Siddiqui RA
J Neurosurg; 2015 Mar; 122(3):547-56. PubMed ID: 25526274
[TBL] [Abstract][Full Text] [Related]
15. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
[TBL] [Abstract][Full Text] [Related]
16. The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines.
Doi T; Ishikawa T; Okayama T; Oka K; Mizushima K; Yasuda T; Sakamoto N; Katada K; Kamada K; Uchiyama K; Handa O; Takagi T; Naito Y; Itoh Y
Oncol Rep; 2017 Mar; 37(3):1545-1554. PubMed ID: 28112370
[TBL] [Abstract][Full Text] [Related]
17. Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis.
Shi Y; Sahu RP; Srivastava SK
BMC Cancer; 2008 Oct; 8():294. PubMed ID: 18847491
[TBL] [Abstract][Full Text] [Related]
18. Antifibrotic Agent Pirfenidone Suppresses Proliferation of Human Pancreatic Cancer Cells by Inducing G0/G1 Cell Cycle Arrest.
Usugi E; Ishii K; Hirokawa Y; Kanayama K; Matsuda C; Uchida K; Shiraishi T; Watanabe M
Pharmacology; 2019; 103(5-6):250-256. PubMed ID: 30731453
[TBL] [Abstract][Full Text] [Related]
19. Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.
Harima H; Kaino S; Takami T; Shinoda S; Matsumoto T; Fujisawa K; Yamamoto N; Yamasaki T; Sakaida I
BMC Cancer; 2016 Aug; 16(1):702. PubMed ID: 27582255
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor properties of the cGMP/protein kinase G inhibitor DT3 in pancreatic adenocarcinoma.
Soltek S; Karakhanova S; Golovastova M; D'Haese JG; Serba S; Nachtigall I; Philippov PP; Werner J; Bazhin AV
Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1121-8. PubMed ID: 26105003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
